title: LC-MS/MS detection of increased androstenedione levels in patients receiving danazol therapy.
authors.affiliation: *Department of Laboratory Medicine, National Institutes of Health Clinical Center, Bethesda, Maryland †National Institutes of Dental and Craniofacial Research, National Institutes of Health, Bethesda, Maryland ‡National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, Maryland §Department of Medicine, Georgetown University, Washington, District of Columbia.
authors.forename: Verena
authors.initials: V
authors.lastname: Gounden
authors.forename: Diala
authors.initials: D
authors.lastname: El-Maouche
authors.forename: Brian R
authors.initials: BR
authors.lastname: Stolze
authors.forename: Ranganath
authors.initials: R
authors.lastname: Muniyappa
authors.forename: Steven J
authors.initials: SJ
authors.lastname: Soldin
mesh_terms: D000735:Androstenedione / Q000097:blood*; D002853:Chromatography, Liquid / Q000592:standards; D003613:Danazol / Q000097:blood* / Q000627:therapeutic use; D004965:Estrogen Antagonists / Q000097:blood* / Q000627:therapeutic use; D005260:Female; D006801:Humans; D008297:Male; D053719:Tandem Mass Spectrometry / Q000592:standards*
chemical_list: D004965:Estrogen Antagonists; D000735:Androstenedione; D003613:Danazol